These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19682793)

  • 41. Endorphins stimulate approach behaviour, but do not reduce subjective fear. A pilot study.
    Arntz A
    Behav Res Ther; 1993 May; 31(4):403-5. PubMed ID: 8390240
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of opioid blockade on the modulation of pain and mood by sweet taste and blood pressure in young adults.
    Lewkowski MD; Young SN; Ghosh S; Ditto B
    Pain; 2008 Mar; 135(1-2):75-81. PubMed ID: 17560720
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Naltrexone alters the processing of social and emotional stimuli in healthy adults.
    Wardle MC; Bershad AK; de Wit H
    Soc Neurosci; 2016 Dec; 11(6):579-91. PubMed ID: 26710657
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The influence of opioid blockage on the sexual response cycle: A randomized placebo-controlled experiment with relevance for the treatment of Compulsive Sexual Behavior Disorder (CSBD).
    Incoronato N; Biedermann SV; Roth L; Müller JC; Fuss J
    Psychoneuroendocrinology; 2023 Jan; 147():105968. PubMed ID: 36356514
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of opiate modulation of pain and nociceptive responding in young adults with a parental history of hypertension.
    France CR; al'absi M; Ring C; France JL; Brose J; Spaeth D; Harju A; Nordehn G; Wittmers LE
    Biol Psychol; 2005 Dec; 70(3):168-74. PubMed ID: 15936866
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Onset, magnitude and duration of opioid blockade produced by buprenorphine and naltrexone in humans.
    Schuh KJ; Walsh SL; Stitzer ML
    Psychopharmacology (Berl); 1999 Jul; 145(2):162-74. PubMed ID: 10463317
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Naltrexone-induced augmentation of sexual response in men.
    Sathe RS; Komisaruk BR; Ladas AK; Godbole SV
    Arch Med Res; 2001; 32(3):221-6. PubMed ID: 11395188
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Psychopharmacological modulation of event-related potentials suggests that first-hand pain and empathy for pain rely on similar opioidergic processes.
    Rütgen M; Seidel EM; Pletti C; Riečanský I; Gartus A; Eisenegger C; Lamm C
    Neuropsychologia; 2018 Jul; 116(Pt A):5-14. PubMed ID: 28438708
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Naltrexone alteration of the nicotine-induced EEG and mood activation response in tobacco-deprived cigarette smokers.
    Knott VJ; Fisher DJ
    Exp Clin Psychopharmacol; 2007 Aug; 15(4):368-81. PubMed ID: 17696684
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endogenous opioids inhibit ambulatory blood pressure during naturally occurring stress.
    McCubbin JA; Bruehl S; Wilson JF; Sherman JJ; Norton JA; Colclough G
    Psychosom Med; 1998; 60(2):227-31. PubMed ID: 9560874
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Opioid antagonism enhances marijuana's effects in heavy marijuana smokers.
    Cooper ZD; Haney M
    Psychopharmacology (Berl); 2010 Aug; 211(2):141-8. PubMed ID: 20490465
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Opioid antagonist impedes exposure.
    Merluzzi TV; Taylor CB; Boltwood M; Götestam KG
    J Consult Clin Psychol; 1991 Jun; 59(3):425-30. PubMed ID: 1677015
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anger management style, opioid analgesic use, and chronic pain severity: a test of the opioid-deficit hypothesis.
    Burns JW; Bruehl S
    J Behav Med; 2005 Dec; 28(6):555-63. PubMed ID: 16320097
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Subjective effects and safety of whole and tampered morphine sulfate and naltrexone hydrochloride (ALO-01) extended-release capsules versus morphine solution and placebo in experienced non-dependent opioid users: a randomized, double-blind, placebo-controlled, crossover study.
    Stauffer J; Setnik B; Sokolowska M; Romach M; Johnson F; Sellers E
    Clin Drug Investig; 2009; 29(12):777-90. PubMed ID: 19888784
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Naltrexone during pain conditioning: A double-blind placebo-controlled experimental trial.
    Pontén M; Fust J; Kosek E; Guterstam J; Jensen K
    Mol Pain; 2020; 16():1744806920927625. PubMed ID: 32538267
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anger management style, blood pressure reactivity, and acute pain sensitivity: evidence for "Trait x Situation" models.
    Burns JW; Bruehl S; Caceres C
    Ann Behav Med; 2004 Jun; 27(3):195-204. PubMed ID: 15184095
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Opioids and social bonding: naltrexone reduces feelings of social connection.
    Inagaki TK; Ray LA; Irwin MR; Way BM; Eisenberger NI
    Soc Cogn Affect Neurosci; 2016 May; 11(5):728-35. PubMed ID: 26796966
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence.
    Jayaram-Lindström N; Konstenius M; Eksborg S; Beck O; Hammarberg A; Franck J
    Neuropsychopharmacology; 2008 Jul; 33(8):1856-63. PubMed ID: 17957221
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stress-evoked opioid release inhibits pain in major depressive disorder.
    Frew AK; Drummond PD
    Pain; 2008 Oct; 139(2):284-292. PubMed ID: 18562104
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Opioid-receptor antagonism increases pain and decreases pleasure in obese and non-obese individuals.
    Price RC; Christou NV; Backman SB; Stone L; Schweinhardt P
    Psychopharmacology (Berl); 2016 Dec; 233(23-24):3869-3879. PubMed ID: 27659699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.